Increased lipid peroxidation in LDL from type-2 diabetic patients

Lipids

Volumn 45, Issue 8, 2010, Pages 723-731

  Colas, Romain ^a,b,c,d,e   Pruneta Deloche, Valérie ^a,b,c,d,e   Guichardant, Michel ^a,b,c,d,e   Luquain Costaz, Céline ^a,b,c,d,e   Cugnet Anceau, Christine ^e   Moret, Myriam ^e   Vidal, Hubert ^a,b,c,d,e   Moulin, Philippe ^a,b,c,d,e   Lagarde, Michel ^a,b,c,d,e   Calzada, Catherine ^a,b,c,d,e  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Univ Lyon   (France)

^d CEMAGREF   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Diabetes; Fast protein liquid chromatography; Fatty acids; Peroxidation; Plasmalogens; Ultracentrifugation

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ALPHA TOCOPHEROL; ARACHIDONIC ACID; CHOLESTEROL ESTER; CORIOLIC ACID; ETHANOLAMINE; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PEROXIDE; PLASMALOGEN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEMALE; HUMAN; HYDROXYLATION; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; ULTRACENTRIFUGATION;

CHOLESTEROL, LDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; ULTRACENTRIFUGATION; VITAMIN E;

EID: 77957883948     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-010-3453-9     Document Type: Article

References (37)

1. Mehta JL, Rasouli N, Sinha AK, Molavi B (2006) Oxidative stress in diabetes: a mechanistic overview of its effects on ath-erogenesis and myocardial dysfunction. Int J Biochem Cell Biol 38:794-803
2. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412
3. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792
4. Griesmacher A, Kindhauser M, Andert SE et al (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469-475
5. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J (1995) Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 368:225-229
6. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G (1995) Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44:60-66
7. Napoli C, Mancini FP, Corso G et al (1997) A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a). J Biochem 121:1096-1101
8. Zambon A, Schmidt I, Beisiegel U, Brunzell JD (1996) Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. J Lipid Res 37:2394-2404
9. Pruneta V, Autran D, Ponsin G et al (2001) Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?. J Clin Endocrinol Metab 86:797-803
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
11. Seppanen-Laakso T, Laakso I, Vanhanen H, Kiviranta K, Lehti-maki T, Hiltunen R (2001) Major human plasma lipid classes determined by quantitative high-performance liquid chromatog-raphy, their variation and associations with phospholipid fatty acids. J Chromatogr B Biomed Sci Appl 754:437-445
12. Browne RW, Armstrong D (2000) HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxi-datively modified human plasma. Clin Chem 46:829-836
13. Therasse J, Lemonnier F (1987) Determination of plasma lipop-eroxides by high-performance liquid chromatography. J Chroma-togr 413:237-241
14. Calzada C, Coulon L, Halimi D et al (2007) In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. J Clin Endocrinol Metab 92:1961-1964
15. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735-2752
16. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by elec-trospray ionization tandem mass spectrometry. J Lipid Res 50:574-585
17. Kuksis A, Myher JJ, Geher K, Breckenridge WC, Jones GJ, Little JA (1981) Lipid class and molecular species interrelationships among plasma lipoproteins of s subjects. J Chromatogr 224:1-23
18. Engelmann B, Brautigam C, Thiery J (1994) Plasmalogen phos-pholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem Biophys Res Commun 204: 1235-1242
19. Esterbauer H, Gebicki J, Puhl H, Jurgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390
20. Barre E (2003) A more detailed fatty acid composition of human lipoprotein(a)-a comparison with low density lipoprotein. Chem Phys Lipids 123:99-105
21. Esterbauer H, Jurgens G, Quehenberger O, Koller E (1987) Autoxidation of human low density lipoprotein: loss of polyun-saturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509
22. Scheek LM, Wiseman SA, Tijburg LB, van Tol A (1995) Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility to oxidation in vitro. Atherosclerosis 117:139-144
23. Stephens JW, Khanolkar MP, Bain SC (2009) The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202:321-329
24. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM (2010) Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 59:1153-1160
25. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1496-1502
26. Packard CJ (2003) Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 31:1066-1069
27. Verges B (2009) Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol 23:681-685
28. Tribble DL, Holl LG, Wood PD, Krauss RM (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-199
29. Jurgens G, Fell A, Ledinski G, Chen Q, Paltauf F (1995) Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens. Chem Phys Lipids 77:25-31
30. Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199-229
31. Niki E (2009) Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47:469-484
32. Mashima R, Onodera K, Yamamoto Y (2000) Regioisomeric distribution of cholesteryl linoleate hydroperoxides and hydroxides in plasma from healthy humans provides evidence for free radical-mediated lipid peroxidation in vivo. J Lipid Res 41:109-115
33. Liu W, Yin H, Akazawa YO, Yoshida Y, Niki E, Porter NA (2010) Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z, E/E, E stereoisomer ratios. Chem Res Toxicol 23:986-995
34. Brenner RR (2003) Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids 68:151-162
35. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C (2000) Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26:387-392
36. Schneider M, Verges B, Klein A et al (2004) Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 53:2633-2639
37. Hunt JV, Smith CC, Wolff SP (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424